PL1652843T3 - Pochodne amidu - Google Patents

Pochodne amidu

Info

Publication number
PL1652843T3
PL1652843T3 PL04748296T PL04748296T PL1652843T3 PL 1652843 T3 PL1652843 T3 PL 1652843T3 PL 04748296 T PL04748296 T PL 04748296T PL 04748296 T PL04748296 T PL 04748296T PL 1652843 T3 PL1652843 T3 PL 1652843T3
Authority
PL
Poland
Prior art keywords
amide derivatives
amide
derivatives
Prior art date
Application number
PL04748296T
Other languages
English (en)
Inventor
Toru Kontani
Junji Miyata
Wataru Hamaguchi
Tomoaki Kawano
Akio Kamikawa
Hiroshi Suzuki
Kenji Sudo
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of PL1652843T3 publication Critical patent/PL1652843T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)
PL04748296T 2003-08-08 2004-08-05 Pochodne amidu PL1652843T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003290850 2003-08-08
PCT/JP2004/011573 WO2005014559A1 (ja) 2003-08-08 2004-08-05 アミド誘導体
EP04748296.3A EP1652843B1 (en) 2003-08-08 2004-08-05 Amide derivatives

Publications (1)

Publication Number Publication Date
PL1652843T3 true PL1652843T3 (pl) 2014-09-30

Family

ID=34114142

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04748296T PL1652843T3 (pl) 2003-08-08 2004-08-05 Pochodne amidu

Country Status (19)

Country Link
US (2) US7465748B2 (pl)
EP (1) EP1652843B1 (pl)
JP (1) JP4549974B2 (pl)
KR (1) KR101157074B1 (pl)
CN (1) CN100445271C (pl)
AU (1) AU2004263448B2 (pl)
BR (1) BRPI0413430B8 (pl)
CA (1) CA2535199C (pl)
CY (1) CY1115461T1 (pl)
DK (1) DK1652843T3 (pl)
ES (1) ES2462292T3 (pl)
MX (1) MXPA06001526A (pl)
NO (1) NO335467B1 (pl)
PL (1) PL1652843T3 (pl)
PT (1) PT1652843E (pl)
RU (1) RU2336273C2 (pl)
SI (1) SI1652843T1 (pl)
TW (1) TW200505894A (pl)
WO (1) WO2005014559A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0402309A3 (en) * 2001-12-21 2008-09-29 Novo Nordisk As Amide derivatives as glucokinase activators and pharmaceutical compositions containing them
PL215132B1 (pl) * 2002-06-27 2013-10-31 Novo Nordisk As Pochodna arylokarbonylowa jako srodek terapeutyczny, jej zastosowanie i kompozycja farmaceutyczna ja zawierajaca
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative
ES2399052T3 (es) 2004-01-06 2013-03-25 Novo Nordisk A/S Heteroaril-ureas y su uso como activadores de glucocinasa
JPWO2006082821A1 (ja) * 2005-02-02 2008-06-26 アステラス製薬株式会社 ヘルペスウイルスが関与する疾患の予防若しくは治療剤
DE602006013938D1 (de) * 2005-02-02 2010-06-10 Astellas Pharma Inc Wirkstoff zur prävention/behandlung von erkrankungen infolge von acyclovir-resistentem herpesvirus
DE602006016069D1 (de) * 2005-02-02 2010-09-23 Astellas Pharma Inc Therapeutischer wirkstoff zur behandlung von herpes progenitalis nach der entwicklung von läsionen
JP5011739B2 (ja) * 2005-02-03 2012-08-29 アステラス製薬株式会社 テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体を含有する医薬組成物
JP2009500378A (ja) * 2005-07-08 2009-01-08 ノボ・ノルデイスク・エー/エス グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
WO2007006760A1 (en) * 2005-07-08 2007-01-18 Novo Nordisk A/S Dicycloalkyl urea glucokinase activators
KR101446973B1 (ko) * 2005-07-14 2014-10-07 트랜스테크 파르마 엘엘씨 우레아 글루코키나제 활성제
WO2008084043A1 (en) * 2007-01-09 2008-07-17 Novo Nordisk A/S Urea glucokinase activators
CA2675111C (en) 2007-01-11 2016-04-05 Novo Nordisk A\S Urea glucokinase activators
DE102008014523A1 (de) * 2008-03-15 2009-09-17 Robert Bosch Gmbh Heizgerät
JP5381978B2 (ja) * 2008-04-02 2014-01-08 アステラス製薬株式会社 アミド誘導体含有医薬組成物
SI2565191T1 (sl) * 2008-05-14 2014-12-31 Astellas Pharma Inc. Derivati 4-(indol-7-ilkarbonilaminometil)cikloheksan karboksilne kisline kot EP4 receptorski antagonisti, uporabni za zdravljenje kronične ledvične odpovedi ali diabetične nefropatije
JPWO2010047295A1 (ja) 2008-10-20 2012-03-22 アステラス製薬株式会社 帯状疱疹関連痛の予防又は治療薬
CN108623577B (zh) * 2018-05-08 2020-09-25 山东百诺医药股份有限公司 阿莫奈韦及其中间体的制备方法
EP3806852A1 (en) 2018-06-12 2021-04-21 vTv Therapeutics LLC Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
WO2020038812A1 (en) * 2018-08-20 2020-02-27 Rijksuniversiteit Groningen New process for the preparation of amenamevir
TW202038947A (zh) 2018-11-28 2020-11-01 德商創新分子有限責任公司 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE9800154A (et) * 1995-12-29 1998-12-15 Boehringer Ingelheim Pharmaceuticals, Inc. Herpesviirusevastaste omadustega fenüültiasoolderivaadid
US6288091B1 (en) * 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
AU3289299A (en) * 1998-02-19 1999-09-06 Tularik Inc. Antiviral agents
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
DE50008597D1 (de) * 1999-03-08 2004-12-16 Bayer Healthcare Ag Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel
AU5283900A (en) * 1999-05-24 2000-12-12 Cor Therapeutics, Inc. Inhibitors of factor xa
WO2000071510A2 (en) * 1999-05-24 2000-11-30 Cor Therapeutics, Inc. INHIBITORS OF FACTOR Xa
CN1473157A (zh) * 2000-11-10 2004-02-04 ֮����ҩ��ʽ���� 酰胺衍生物
DE10139060A1 (de) 2001-08-08 2003-02-20 Merck Patent Gmbh Phenylderivate
WO2003095435A1 (fr) 2002-05-09 2003-11-20 Yamanouchi Pharmaceutical Co., Ltd. Derives d'amides
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative

Also Published As

Publication number Publication date
DK1652843T3 (da) 2014-05-05
NO335467B1 (no) 2014-12-15
RU2336273C2 (ru) 2008-10-20
KR20060073928A (ko) 2006-06-29
EP1652843B1 (en) 2014-04-02
TW200505894A (en) 2005-02-16
BRPI0413430B1 (pt) 2019-04-30
JP4549974B2 (ja) 2010-09-22
RU2006106922A (ru) 2006-08-27
CN1832930A (zh) 2006-09-13
CY1115461T1 (el) 2017-01-04
JPWO2005014559A1 (ja) 2006-10-05
CA2535199C (en) 2010-12-14
US7465748B2 (en) 2008-12-16
SI1652843T1 (sl) 2014-06-30
BRPI0413430B8 (pt) 2021-05-25
AU2004263448A1 (en) 2005-02-17
EP1652843A1 (en) 2006-05-03
NO20061100L (no) 2006-03-07
CA2535199A1 (en) 2005-02-17
US6903125B2 (en) 2005-06-07
MXPA06001526A (es) 2006-05-25
US20050032855A1 (en) 2005-02-10
KR101157074B1 (ko) 2012-06-22
AU2004263448B2 (en) 2009-02-05
ES2462292T3 (es) 2014-05-22
CN100445271C (zh) 2008-12-24
TWI341311B (pl) 2011-05-01
BRPI0413430A (pt) 2006-10-17
US20060229295A1 (en) 2006-10-12
EP1652843A4 (en) 2010-07-28
WO2005014559A1 (ja) 2005-02-17
PT1652843E (pt) 2014-06-02

Similar Documents

Publication Publication Date Title
HK1091830A1 (en) Amide derivatives
IL211894A0 (en) Amide derivatives
HK1088602A1 (en) 2-pyridinecarboxamide derivatives
HK1088326A1 (en) Piperidine-benzenesulfonamide derivatives
HK1089443A1 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
GB0317665D0 (en) Qinazoline derivatives
IL183657A0 (en) Amide derivatives
PT1682493E (pt) Derivados de aminoacetonitrilo
HK1091204A1 (en) Heteroarylcarbamoylbenzene derivative
IL204829A0 (en) Aniline derivatives
IL176562A0 (en) Amidopyrazole derivative
IL175189A0 (en) N-thiazol-2-yl-benzamide derivatives
TWI368482B (en) New 2-pyridinylethylbenzamide derivatives
SI1652843T1 (sl) Amidni derivati
ZA200602131B (en) Amide type carboxamide derivatives
GB0329572D0 (en) Amide derivatives
PT1706373E (pt) Derivados de amidoacetonitrilo
GB2403474B (en) Amide derivatives
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
AU2003235889A8 (en) Amide derivatives
GB0319793D0 (en) Pyridinylmorpholine derivatives
ZA200705150B (en) Amide derivatives
GB0324789D0 (en) Amide derivatives
GB0315320D0 (en) Amide derivative
AU2003280821A8 (en) Beauveriolide derivative